Devyser Diagnostics AB Total Liabilities

Latest as of June 2026: Skr112.10 Million SEK ≈ $12.06 Million USD

Devyser Diagnostics AB total liabilities. Based on the latest financial reports, Devyser Diagnostics AB (DVYSR) has total liabilities worth Skr112.10 Million SEK (≈ $12.06 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Devyser Diagnostics AB to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Devyser Diagnostics AB (2018–2025)

Total liabilities of Devyser Diagnostics AB from 2018 to 2025. This chart illustrates how Devyser Diagnostics AB's total liabilities have evolved over time, based on quarterly financial data.

Devyser Diagnostics AB Competitors by Total Liabilities

The table below lists competitors of Devyser Diagnostics AB ranked by their total liabilities.

Company	Country	Total Liabilities
Data International Co Ltd TWO:5432	Taiwan	NT$65.56 Million
Gold Resource Corporation NYSE MKT:GORO	USA	$138.38 Million
Kulmbacher Brauerei Aktien-Gesellschaft MU:KUL	Germany	€168.79 Million
Adel Kalemcilik Ticaret ve Sanayi AS IS:ADEL	Turkey	TL2.08 Billion
Yapi Kredi Koray Gayrimenkul Yatirim Ortakligi AS IS:KGYO	Turkey	TL8.76 Billion
Willbes KO:008600	Korea	₩199.46 Billion
Anavex Life Sciences Corp NASDAQ:AVXL	USA	$7.69 Million
Creative Newtech Limited NSE:CREATIVE	India	Rs4.47 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Devyser Diagnostics AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Devyser Diagnostics AB (DVYSR) total assets.

Liquidity & Leverage Metrics

Devyser Diagnostics AB Total Liabilities Ratios Explained

Devyser Diagnostics AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.29	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Devyser Diagnostics AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Devyser Diagnostics AB (2018–2025)

The table below shows the annual total liabilities of Devyser Diagnostics AB from 2018 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr115.40 Million ≈ $12.42 Million	-7.53%
2024-12-31	Skr124.80 Million ≈ $13.43 Million	-0.16%
2023-12-31	Skr125.00 Million ≈ $13.45 Million	+80.66%
2022-12-31	Skr69.19 Million ≈ $7.45 Million	+72.19%
2021-12-31	Skr40.18 Million ≈ $4.32 Million	-7.80%
2020-12-31	Skr43.58 Million ≈ $4.69 Million	+18.78%
2019-12-31	Skr36.69 Million ≈ $3.95 Million	+101.02%
2018-12-31	Skr18.25 Million ≈ $1.96 Million	--

About Devyser Diagnostics AB

ST:DVYSR Sweden Medical Devices

Market Cap

$116.87 Million

Skr1.09 Billion SEK

Market Cap Rank

#18405 Global

#315 in Sweden

Share Price

Skr64.30

Change (1 day)

-0.77%

52-Week Range

Skr49.75 - Skr120.00

All Time High

Skr157.80